Cargando…
EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
The identification and validation of prognostic and diagnostic biomarkers is a key element of The SIOP Ependymoma II trial, realised through the Biomarkers of Ependymoma in Children and Adolescents study (BIOMECA). BIOMECA aims to identify and validate biomarkers for prediction of outcome whilst enh...
Autores principales: | Chapman, Rebecca, Ghasemi, David R, LeBlond, Pierre, Witt, Hendrik, Grill, Jacques, Kilday, John-Paul, Modena, Piergiorgio, Varlet, Pascale, Tauziede-Espariat, Arnault, Haberler, Christine, Buttarelli, Francesca, Giangaspero, Felice, Paine, Simon M L, Jacques, Thomas S, Scott, Ian, Andreiuolo, Felipe, Pietsch, Torsten, Massimino, Maura, Grundy, Richard, Pajtler, Kristian W, Ritzmann, Timothy A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164839/ http://dx.doi.org/10.1093/neuonc/noac079.160 |
Ejemplares similares
-
EPEN-02. OPTIMISING BIOMARKERS FOR ACCURATE EPENDYMOMA DIAGNOSIS, PROGNOSTICATION AND STRATIFICATION WITHIN INTERNATIONAL CLINICAL TRIALS: A BIOMECA STUDY
por: Chapman, Rebecca J, et al.
Publicado: (2023) -
EPEN-04. SIOP EPENDYMOMA I: FINAL RESULTS, LONG TERM FOLLOW-UP AND MOLECULAR ANALYSIS OF THE TRIAL COHORT: A BIOMECA CONSORTIUM STUDY
por: A. Ritzmann, Timothy, et al.
Publicado: (2021) -
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
por: Chapman, Rebecca J, et al.
Publicado: (2023) -
EPEN-05. Adenosine receptor expression in paediatric ependymoma
por: Spanoudakis, Chelsea, et al.
Publicado: (2022) -
EPEN-47. PEDS: PEDIATRIC EPENDYMOMA DISCOVERY STUDY
por: Smith, Amy, et al.
Publicado: (2020)